All In MedTech

Device Trial Radar · NCT05616104

FLEX FIRST Registry Research Protocol

Last checked: Nov 20, 2026Latest source record: Aug 7, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

130

Actual

Start

Nov 29, 2022

Primary completion

Feb 1, 2025

Study completion Aug 4, 2025

Sponsor

Lead sponsor
VentureMed Group Inc.Not on our public-company list
Sponsor type
Industry
First posted
Nov 15, 2022

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Prospective, observational study evaluating the clinical use and outcomes of the FLEX Vessel Prep (VP) system in arteriovenous fistulae or grafts presenting with clinical or hemodynamic abnormalities following 12 months post treatment.

Conditions

  • Arteriovenous Fistula
  • Arteriovenous Graft
  • Fistula
  • Arterial Occlusive Diseases

Interventions

  • FLEX Vessel Prep SystemDevice

    The FLEX Vessel Prep System to create circumferential, continuous micro-incisions along the length of the stenosis by performing a retrograde pullback through the lesion. Following FLEX, standard balloon angioplasty is performed with an uncoated PTA balloon sized to meet the reference vessel diameter, according to its corresponding Instructions for Use. Once advanced into the lesion, the balloon should be inflated according to the site's standard of care.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Target Lesion Primary Patency RateTime frame: 6 months post procedure

1 more outcomes with a free account

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Open Access Vascular Access

    Miami, Florida

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.